標籤: ren001

Results to Form Part of Data Package to the US FDA In Support of Application to Commence Clinical Studies with ReN001-. Guildford,UK, 9 October 2006: ...

ReNeuron appoints Principal Investigator for Phase l clinical study with its ReN001 stem cell therapy for stroke. 23/08/06. ReNeuron Group plc (LSE: RENE) ...

ReN001, a human neural stem cell line also called CTX0E03, was created by genetically modifying human somatic stem cells with a conditional immortalizing ...

2019年3月5日 - Official Title: An Open-label Study to Evaluate the Safety and Tolerability of 12 Weeks Treatment With Oral REN001 in Patients With Primary ...

2007年10月21日 - ReN001 is a clonal human neural stem cell line developed for clinical use in the treatment of stable disability after stroke. ReN001 a strong ...

ReN 001, a manufactured neural stem cell line (CTX) is being developed by ReNeuron for the treatment of stroke. This therapy contains CTX stem cells which ...

2019年2月6日 - Official Title: An Open Label Study to Determine the Safety and Tolerability of 12 Weeks Treatment With Oral REN001 in Subjects With Fatty ...

2008年1月1日 - A clonal human neural stem cell line (ReN001) has been developed for clinical use in the treatment of stable disability after stroke. This cell line ...